Age and Ageing, Vol 28, 359-362, Copyright © 1999 by British Geriatrics Society
JG Doherty, A Rufer, P Bartholomew and DM Beaumont
OBJECTIVE: To review clinical presentation and outcome of patients with a
diagnosis of renal cell carcinoma at a district general hospital and assess
whether older patients were more likely to present in a non- specific
manner or receive more conservative management and whether their survival
was less favourable. SUBJECTS AND METHODS: 39 patients presenting with a
diagnosis of renal cell carcinoma between 1987 and 1995 were identified
from hospital activity analysis data and histopathology records. We divided
the subjects into young patients (< 69 years: n = 27) and elderly
patients (>70 years: n = 10), and made a retrospective analysis of
clinical features, laboratory results, pathology, staging, treatment and
survival from hospital records. RESULTS: Anaemia, hypertension and weight
loss were common clinical features in both young and elderly groups. The
prevalence of non- urological symptoms did not differ between study groups.
Anaemia was frequently microcytic and hypochromic. Hypertension was present
in 46% of patients and one-third of these were newly diagnosed. In 19% of
patients with renal cell carcinoma, the diagnosis was made incidentally
while imaging for other indications. Elderly patients were as likely to
receive surgical treatment as younger patients. Survival differed with
stage but not age. CONCLUSIONS: Neither clinical presentation, management
nor survival differed between the young and elderly subjects. Renal cell
carcinoma should be considered in elderly patients with systemic features
such as malaise or weight loss associated with anaemia, hypertension and
raised erythrocyte sedimentation rate.
ARTICLES
The presentation, treatment and outcome of renal cell carcinoma in old age
Department of Geriatric Medicine, Queen Elizabeth Hospital, Sheriff Hill, UK.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
T. Eisen, S. Oudard, C. Szczylik, G. Gravis, H. Heinzer, R. Middleton, F. Cihon, S. Anderson, S. Shah, R. Bukowski, et al. Sorafenib for Older Patients With Renal Cell Carcinoma: Subset Analysis From a Randomized Trial J Natl Cancer Inst, October 15, 2008; 100(20): 1454 - 1463. [Abstract] [Full Text] [PDF] |
||||
